Back to Journals » Journal of Inflammation Research » Volume 18
Serum Levels of IL-6, IL-10, TNF-α, and Vitamin D: Their Correlation with Acute Otitis Media in Short-Stature Pediatric Patients
Authors Dermawan A , Ropii B, Lasminingrum L , Hasansulama W, Setiabudiawan B
Received 20 November 2024
Accepted for publication 18 February 2025
Published 24 April 2025 Volume 2025:18 Pages 5533—5543
DOI https://doi.org/10.2147/JIR.S500675
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Prof. Dr. Kattepura Krishnappa Dharmappa
Arif Dermawan,1 Bejo Ropii,2 Lina Lasminingrum,1 Wijana Hasansulama,1 Budi Setiabudiawan3,4
1Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital Bandung, Bandung, 40161, Indonesia; 2Departemen of Biomedical Engineering, Preanger Institute for Biomedical Engineering, Science, and Technology, Bandung, Indonesia; 3Department of Child Health, Faculty of Medicine Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital, Bandung, 40161, Indonesia; 4Faculty of Medicine President University, Cikarang, Bekasi, 17550, Indonesia
Correspondence: Arif Dermawan, Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital Bandung, Bandung, 40161, Indonesia, Email [email protected]
Introduction: Short stature in children is a global health issue often linked to micronutrient deficiencies like vitamin D, potentially impairing immune function. Acute Otitis Media (AOM) is a common complication of upper respiratory infections in children, with inflammatory cytokines such as IL-6, IL-10, and TNF-α playing a crucial role in its pathogenesis. This study aims to explore the correlation between serum levels of these biomarkers and AOM occurrence in short-stature pediatric patients.
Purpose: To assess the relationship between serum levels of IL-6, IL-10, TNF-α, and vitamin D and their association with AOM in children with short stature.
Patients and Methods: A case-control study was conducted with 180 children aged 24– 59 months, divided into four groups: short stature with AOM, short stature without AOM, normal stature with AOM, and normal stature without AOM. Serum levels of IL-6, IL-10, TNF-α, and vitamin D were measured using the ELISA method. The data were analyzed using descriptive, bivariate, and multivariate statistical methods.
Results: Children with short stature and AOM had the highest median levels of IL-6 (12.15 pg/mL) and TNF-α (162.52 pg/mL), while IL-10 levels were lowest in this group (0.56 pg/mL), indicating a robust inflammatory response associated with AOM. Multivariate analysis revealed that male sex, vitamin D levels ≤ 18.9 ng/mL, IL-6 levels > 9.42 pg/mL, and IL-10 levels ≤ 0.76 pg/mL were significant risk factors for developing AOM, with respective odds ratios indicating markedly elevated risks.
Conclusion: This study underscores the significant role of inflammatory markers and vitamin D deficiency in the development of AOM in short-stature pediatric patients. Regular monitoring and targeted interventions may help prevent AOM in this vulnerable population, warranting future research on the effectiveness of vitamin D supplementation and other therapeutic strategies.
Keywords: acute otitis media, AOM, IL-6, TNF-α, inflammatory cytokines, short stature, vitamin D deficiency
Introduction
Short stature in children is a persistent global health issue, with its prevalence continuing to rise across various regions.1,2 According to the 2018 Joint Child Malnutrition Estimates, 22.2% or 150.8 million children under the age of five worldwide were affected by short stature in 2017.3 This condition is often linked to both macronutrient and micronutrient deficiencies, with studies in developing countries like India and Pakistan identifying malnutrition and normal variance as primary causes.4,5 In Indonesia, short stature remains prevalent, with the 2018 Riskesdas survey reporting a prevalence of 31.06% among children under five in West Java Province, reaching 40.7% in Bandung city.6
Malnutrition, macronutrient deficiencies (protein-energy malnutrition) and micronutrient deficiencies (such as vitamin and mineral deficiencies), is the leading cause of short stature and is associated with decreased leptin levels, which disrupt immune regulation.7,8 In addition to nutritional deficiencies, hormonal imbalances involving growth hormone (GH) and insulin-like growth factor-1 (IGF-1) also contribute to impaired growth. Reduced IGF-1 levels can lead to thymus atrophy and altered T-cell differentiation, which compromises immune function and increases susceptibility to infections.9,10
Vitamin D deficiency is another factor that has been strongly associated with compromised immune function and an increased risk of infections in early childhood.11 In particular, it has been linked to a higher incidence of upper respiratory tract infections (URTI) in children, with complications such as acute otitis media (AOM) being common. AOM affects a significant proportion of children, particularly those aged 6 months to 3 years, and has been associated with lower serum levels of 25-hydroxyvitamin D.12,13 Studies have also shown that children with short stature often have vitamin D deficiency, further compounding their risk of infections such as AOM.14,15
The pathophysiology of AOM involves an inflammatory response within the middle ear, characterized by the accumulation of pro-inflammatory cytokines like tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and anti-inflammatory cytokines like interleukin-10 (IL-10). These cytokines play critical roles in the immune response and are key mediators in the inflammatory process of AOM. Without timely treatment, AOM can lead to serious health complications. Despite the well-established role of vitamin D and inflammatory cytokines in immune regulation, there is a lack of research examining their specific involvement in the development of AOM in children with short stature. This study aims to explore the relationship between serum levels of vitamin D, IL-6, TNF-α, and IL-10, and the occurrence of AOM in short-stature pediatric patients, providing insight into the potential role of these biomarkers in both the prevention and management of AOM in this vulnerable population.
Materials and Methods
This study employed a case-control design, involving children aged 24 to 59 months, who were categorized into four groups: short stature with AOM, short stature without AOM, normal stature with AOM, and normal stature without AOM. The study took place between July 2019 and February 2020 at 30 primary healthcare centers in Bandung Regency, using a multistage random sampling method. Ethical clearance was obtained from the Research Ethics Committee of the Faculty of Medicine, Padjadjaran University. The study was conducted in accordance with the principles of the Declaration of Helsinki. Informed consent was collected from the parents or guardians of all participating children prior to their inclusion in the study.
Sampling and Height Measurements
Participants were selected based on specific inclusion and exclusion criteria. The inclusion criteria required children aged 24 to 59 months residing in Bandung Regency, while the exclusion criteria ruled out children who moved during the study period, as well as those with severe illnesses, congenital abnormalities, or conditions such as Down syndrome. A total of 800 children were selected from 1544 child records across 39 healthcare facilities in the Bandung region. The children’s height was measured to categorize them as either having short stature or normal stature, following WHO standards. Children with a height-for-age Z-score < −2SD were classified as having short stature, while those between −2SD and 2SD were considered of normal height. After the informed consent process, interviews were conducted to collect data, which was verified using the Acute Otitis Media (AOM) questionnaire.
Measurement of 25(OH)D, IL-6, TNF-α, and IL-10
Blood samples were collected to measure serum levels of 25-hydroxyvitamin D (25(OH)D), IL-6, TNF-α, and IL-10. The 25(OH)D samples were obtained from the 2018–2019 ALG study and stored at −80°C prior to analysis. The levels were measured using the Enzyme-Linked Immunosorbent Assay (ELISA) method, with a wavelength of 405 nm and Euroimmune reagent kits. IL-6, TNF-α, and IL-10 concentrations were determined using the Sandwich ELISA technique with reagents from E lab science, kept at 18–25°C. The ELISA microplate was coated with human polyclonal antibodies, and results were measured using a spectrophotometer at 450 nm. All laboratory tests were conducted at the Clinical Pathology Laboratory of Hasan Sadikin Hospital in Bandung, with data analyzed as participant numbers increased.
AOM Questionnaire and Tympanometry Measurements
To assess the severity of AOM, a questionnaire was administered to parents or guardians, which included demographic information and specific questions related to AOM, adapted from the PERHATI-KL Otology Study Group Questionnaire. Tympanometry measurements were also conducted as an objective evaluation of middle ear function, measuring tympanic membrane mobility and impedance values in the auditory ossicles. The results were classified into five categories: A, B, As, Ad, and C, reflecting different degrees of middle ear pathology.
Statistical Data Analysis
The data were analyzed using descriptive, bivariate, and multivariate statistical methods. Descriptive statistics included frequencies and percentages for categorical variables and means and standard deviations for continuous variables. The Shapiro–Wilks test was applied to check for normal distribution. Group comparisons of 25(OH)D, IL-6, TNF-α, and IL-10 levels were analyzed using bivariate methods such as ANOVA, Kruskal–Wallis, Chi-Square, Fisher’s Exact Test, and the Kolmogorov–Smirnov test. Multivariate analysis was conducted to assess the effect of multiple risk factors on AOM. Statistical significance was defined as a p-value ≤ 0.05, with values above 0.05 considered non-significant.
Results
The study involved 180 children, divided into four groups: 48 children with short stature and acute otitis media (AOM), 44 with short stature without AOM, 44 with normal stature and AOM, and 44 with normal stature without AOM. Basic characteristics, including age, gender, exclusive breastfeeding, exposure to cigarette smoke, parental education, occupation, and income, were compared across groups to evaluate potential confounding variables (Table 1). Categorical variables were reported as frequencies and proportions, while numerical variables were expressed as medians with interquartile ranges (IQR) due to non-normal data distribution. Chi-square analysis revealed a statistically significant difference between genders among study groups, with boys more likely to experience AOM than girls, particularly in the short stature group (p=0.006).
![]() |
Table 1 Characteristic of Research Subjects |
Vitamin D status was assessed by measuring serum 25(OH)D levels and categorized as sufficient (≥30 ng/mL), insufficient (21–29 ng/mL), or deficient (≤20 ng/mL) based on Endocrine Society guidelines (Table 2). It was found that Chi-square analysis demonstrated a significant association between group categorization and vitamin D status (p < 0.001). In the short-stature group with AOM, the majority of children had vitamin D deficiency (33 children), followed by insufficiency (14 children). In the short-stature group without AOM, vitamin D insufficiency was more common (26 children), followed by deficiency (15 children). There was a significant difference in vitamin D status between the short-stature group with AOM and the normal stature group with AOM, where the latter was dominated by insufficiency (29 children) and deficiency (9 children). Similarly, the vitamin D status in the short-stature group with AOM was significantly different from the normal stature group without AOM, which was dominated by insufficiency (22 children) and normal levels (13 children). Children with short stature and AOM exhibited a notable difference in vitamin D levels compared to those without AOM, with a higher prevalence of vitamin D deficiency. This suggests a strong correlation between vitamin D deficiency, short stature, and the presence of AOM. However, there was no significant difference in vitamin D status between the short-stature group without AOM and the normal stature group with AOM (p = 0.105), both of which were dominated by insufficiency followed by deficiency. This suggests that either AOM, short stature, or both conditions may be linked to vitamin D insufficiency or deficiency. Lastly, there was a significant difference in vitamin D status between the normal stature group without AOM and the short stature group without AOM, but no significant difference between the normal stature group without AOM and the normal stature group with AOM (p = 0.252).
![]() |
Table 2 Status of Vitamin D Among Research Group |
The IL-6 concentrations across the four groups are presented as medians and IQRs (Table 3). The short stature group with AOM showed the highest median IL-6 level of 12.15 pg/mL, reflecting a significant inflammatory response. In contrast, the short stature group without AOM had a lower median IL-6 of 8.50 pg/mL. The normal stature group with AOM had a median IL-6 of 1.18 pg/mL, while the normal stature group without AOM showed the lowest median IL-6 of 0.62 pg/mL. Statistical analysis indicated a significant difference in IL-6 levels among the four groups (p < 0.001), with each group displaying distinct IL-6 levels, underscoring the variation in inflammatory responses.
![]() |
Table 3 Comparison of IL-6 Levels in Four Study Groups |
The IL-10 levels varied significantly across the groups (Table 4). The short stature group with AOM had the lowest median IL-10 level of 0.56 pg/mL, compared to the short stature group without AOM, which had a median IL-10 of 1.56 pg/mL. In the normal stature group with AOM, the median IL-10 level was substantially higher at 8.32 pg/mL, while the normal stature group without AOM had the highest median IL-10 level of 14.69 pg/mL. Statistical analysis confirmed significant differences in IL-10 levels among all four groups (p < 0.001), suggesting an inverse relationship between IL-10 levels and the severity of inflammation in short stature children with AOM.
![]() |
Table 4 Comparison of IL-10 Levels in Four Study Groups |
The TNF-α concentrations were highest in the short stature group with AOM, with a median level of 162.52 pg/mL, indicating a pronounced inflammatory response in this group (Table 5). The short stature group without AOM followed with a median TNF-α of 141.84 pg/mL. The normal stature group with AOM had a lower median TNF-α level of 122.36 pg/mL, while the normal stature group without AOM showed the lowest TNF-α level at 97.09 pg/mL. Despite these differences, statistical analysis showed no significant difference in TNF-α levels between the short stature groups with and without AOM (p = 0.214), suggesting that TNF-α levels alone may not serve as a reliable marker for AOM in children with short stature.
![]() |
Table 5 Comparison of TNF-α Levels in Four Study Groups |
To analyze the multivariable relationship between 25(OH)D, IL-6, TNF-α, and IL-10 levels, a multivariate logistic regression analysis was performed. Since 25(OH)D, IL-6, TNF-α, and IL-10 levels are numerical data, the receiver operating characteristic (ROC) curve was first used to determine the cut-off values. The ROC curve analysis results are presented in Table 6.
![]() |
Table 6 Cut-off Values for 25(OH)D. IL-6. TNF-α. and IL-10 Levels in Predicting Acute Otitis Media in Short-Stature Children |
Table 7 provides the results of the multivariable analysis, which included variables with highly significant p-values from the bivariate analysis: gender, 25(OH)D levels ≤18.9 ng/mL, IL-6 levels >9.42 pg/mL, and IL-10 levels ≤ 0.76 pg/mL. Based on the multivariate analysis shown in Table 8, it was found that short-stature male children have a 3.80 times higher risk of developing acute otitis media (AOM), short-stature children with 25(OH)D levels ≤18.9 ng/mL have a 5.49 times higher risk, those with IL-6 levels >9.42 pg/mL have a 67.58 times higher risk, and children with IL-10 levels ≤0.76 pg/mL have a 29.20 times higher risk of developing AOM.
![]() |
Table 7 The Relationship Between Cut-off Values of 25(OH)D. IL-6. TNF-α. and IL-10 Levels with Acute Otitis Media in Short-Stature Children |
![]() |
Table 8 Multivariable Analysis of Factors Associated with Acute Otitis Media in Short-Stature Children (Final Model) |
Discussion
Vitamin D, a fat-soluble vitamin, has gained recognition for its extensive biological effects beyond calcium homeostasis and bone metabolism. It plays a key role in modulating both innate and adaptive immune responses, with vitamin D receptors (VDRs) present on various immune cells, including monocytes, macrophages, dendritic cells, and lymphocytes. The active form, 1,25-dihydroxyvitamin D3, enhances antimicrobial peptide production, such as cathelicidin and defensins, which are vital in the innate immune response against pathogens.16 Moreover, it regulates the adaptive immune system, promoting regulatory T cells while suppressing pro-inflammatory cytokines like IL-17 and IFN-γ.14,17 These immune-related effects are relevant to conditions like asthma, where vitamin D deficiency has been associated with exacerbations and reduced airway inflammation in children.18,19
The relationship between vitamin D and short stature has also been well-documented. Studies show that children with short stature tend to have a higher prevalence of vitamin D deficiency compared to those with normal height.14,20–22 This deficiency impacts the growth plate, impairing linear growth through reduced chondrocyte proliferation and differentiation, as well as diminished expression of key growth factors like IGF-1 and FGF-21.23,24 Furthermore, vitamin D deficiency has been shown to negatively affect the GH-IGF-1 axis, essential for bone growth and development.25 Research supports the use of vitamin D supplementation to improve growth outcomes in children with short stature and deficiency.26
In our study, we found a significant association between vitamin D deficiency, elevated inflammatory markers (IL-6, IL-10, and TNF-α), and increased risk of acute otitis media (AOM) in children with short stature. Children with short stature and AOM exhibited higher levels of IL-6 and lower levels of IL-10 compared to other groups. Elevated IL-6 levels suggest an enhanced inflammatory response, contributing to AOM’s persistence.27,28 The decreased IL-10 levels indicate an impaired resolution of inflammation, prolonging infection susceptibility.29
While the role of TNF-α in AOM has been debated, our study found no significant difference in TNF-α levels between children with short stature with or without AOM, indicating it may not serve as a reliable biomarker in this context. This observation reflects the complexity of the inflammatory response, which involves multiple pathways and factors.30
We evaluated the diagnostic accuracy of vitamin D, IL-6, IL-10, and TNF-α levels in predicting AOM in children with short stature. IL-10 emerged as the most accurate biomarker, followed by IL-6 and vitamin D, while TNF-α showed the lowest predictive value. These findings suggest that vitamin D deficiency, combined with altered inflammatory marker levels, may serve as indicators for AOM risk in this population.
Based on multivariable analysis, the factors associated AOM in children with short stature include male sex, 25(OH)D levels ≤18.9 ng/mL, IL-6 levels >9.42 pg/mL, and IL-10 levels ≤0.76 pg/mL. Short-statured boys are at a fourfold increased risk of developing AOM compared to girls. The study findings reveal a notable gender disparity, with short-statured male children at a significantly higher risk of developing Acute Otitis Media (AOM) compared to their female counterparts. Several factors may explain this gender difference. Anatomical differences between boys and girls, particularly in the structure of the Eustachian tube, may contribute to the increased susceptibility of boys to Acute Otitis Media (AOM). In children, the Eustachian tube is shorter and more horizontal compared to adults, which can impair the drainage of the middle ear and make it more susceptible to infections like AOM. Furthermore, research indicates that the average length of the cartilaginous and bony parts of the Eustachian tube is smaller in women than in men, which may affect the function of the Eustachian tube and contribute to the increased risk of AOM in boys.31–33 Additionally, hormonal differences could play a role. Estrogen, which is more prevalent in girls, has been shown to have protective effects on the immune system, potentially offering girls more resistance to infections like AOM. Moreover, immune system differences between genders could contribute to the disparity; females typically have stronger immune responses, which may confer protection against infections.31–33 Environmental factors, such as increased exposure to risk factors like daycare attendance, passive smoke exposure, and respiratory infections, may also differ between genders and influence AOM susceptibility. Genetic predispositions specific to boys may further contribute to this heightened risk. The study’s results are consistent with prior research that has found male sex to be a significant risk factor for otitis media, further emphasizing the importance of considering gender in the management and prevention of AOM in pediatric populations. Understanding these underlying factors can help pediatricians and healthcare professionals identify children at higher risk for AOM, especially those with short stature, vitamin D deficiency, and elevated inflammatory markers like IL-6 and IL-10, and develop targeted preventive strategies.
Short-statured children with 25(OH)D levels ≤18.9 pg/mL have a 5.49-fold increased risk of developing AOM compared to those with levels >18.9 pg/mL. There are no previous reports explicitly linking vitamin D levels to AOM in this context. However, various studies have examined the correlation between vitamin D and otitis media, suggesting that vitamin D deficiency is associated with an increased risk of otitis media. A systematic review and meta-analysis by indicated that lower vitamin D levels are linked to otitis media.34 Furthermore, a systematic review and meta-analysis reported that patients with otitis media had lower serum vitamin D levels.35 Children with IL-6 levels >9.42 pg/mL are at a 67.58-fold increased risk of developing AOM compared to those with IL-6 levels ≤9.42 pg/mL.35 Although previous studies have not reported on this specific relationship, Serban et al (2021) demonstrated that elevated IL-6 concentrations correlate with otitis media in children, implicating IL-6 in the inflammatory response associated with otitis media.36 Additionally, short-statured children with IL-10 levels ≤0.76 pg/mL are at a 29.30-fold increased risk of developing AOM compared to those with IL-10 levels >0.76 pg/mL, though there are no prior studies documenting this finding.36
The multivariable analysis yielded an R² (Nagelkerke) value of 0.688, indicating that 68.8% of AOM cases in short-statured children can be attributed to the four aforementioned factors: male sex, 25(OH)D levels, IL-6 levels, and IL-10 levels. The remaining 31.2% may be influenced by other unexamined factors in this study.
Overall, our results underscore the importance of vitamin D status in modulating immune responses and inflammatory processes in children with short stature and AOM. The findings also align with previous research linking vitamin D deficiency to both impaired growth and increased susceptibility to infections.21,31–33 Short stature itself may reflect underlying endocrine dysfunctions, such as disturbances in the GH-IGF-1 axis, which has been linked to immune modulation. IGF-1 deficiency could impair mucosal immunity, leading to an increased risk of recurrent infections like AOM. Additionally, chronic low-grade inflammation in short-stature children, as indicated by elevated TNF-α and IL-6 levels, may contribute to an exaggerated immune response, further predisposing them to infections. This immune imbalance, coupled with vitamin D deficiency, may explain the increased susceptibility to AOM in short-stature children. Furthermore, the observed male predominance in AOM cases could be attributed to sex-based differences in immune responses, where boys tend to exhibit higher pro-inflammatory cytokine activity and lower regulatory cytokine levels. Further studies are needed to clarify the role of vitamin D supplementation in preventing AOM and to validate the use of these biomarkers in clinical settings.
This study has several limitations. First, the relatively wide 95% confidence interval may be attributed to the small sample size, despite meeting the minimum required number of subjects. A smaller sample size can lead to greater variability in estimates, resulting in wider confidence intervals. While the wide confidence interval indicates the need for more data to obtain more precise parameter estimates, it still encompasses values with clinically significant implications, warranting further research with a larger cohort. Second, there may be confounding variables that could influence the independent variables (25(OH)D, IL-6, TNF-α, and IL-10) or the dependent variable (AOM), which could not be measured in this study. These confounders include sunlight exposure, nutritional intake, allergens, pollutants, and genetic factors. Long-term follow-up studies are needed to assess changes in 25(OH)D, IL-6, TNF-α, and IL-10 levels, as well as the progression of AOM, to clarify and validate the impact of these variables on AOM in children with short stature.
Conclusion
This study highlights the complex interplay between short stature, vitamin D deficiency, and inflammatory markers in pediatric patients, particularly concerning the risk of Acute Otitis Media (AOM). Our findings reveal that children with short stature and AOM exhibit significantly elevated levels of IL-6 and TNF-α, indicating a pronounced inflammatory response compared to their counterparts without AOM. The notably low levels of IL-10 in this group further suggest an impaired regulatory response to inflammation, which may contribute to the heightened susceptibility to AOM in these children.
The multivariate analysis underscores critical risk factors for developing AOM, including male gender and low serum levels of vitamin D, IL-6, and IL-10. Specifically, male children with vitamin D levels ≤18.9 ng/mL and IL-6 levels >9.42 pg/mL face markedly increased odds of experiencing AOM, which aligns with previous literature highlighting the influence of gender on the incidence of ear infections in pediatric populations.
These results advocate for a multifaceted approach to managing children with short stature. Addressing vitamin D deficiency and monitoring inflammatory markers could provide essential insights for predicting and preventing AOM in this vulnerable group. Additionally, the strong correlation between vitamin D status and inflammatory responses calls for further investigation into the therapeutic benefits of vitamin D supplementation in improving immune function and reducing the incidence of AOM.
Given the significant association between vitamin D deficiency and increased risk of AOM in children with short stature, we recommend regular screening for vitamin D levels in this population. Healthcare providers should consider implementing vitamin D supplementation strategies, alongside monitoring inflammatory markers, to enhance immune response and mitigate the risk of AOM. Future research should focus on the long-term effects of vitamin D supplementation on the incidence of AOM and overall health outcomes in children with short stature. Based on the findings, OME screening should also be considered for children with short stature, particularly males, who are at a higher risk of developing AOM. Studies show that male children have anatomical differences that predispose them to a higher incidence of ear infections, including OME. Given the established risk factors—such as vitamin D deficiency, inflammation, and male gender—it would be prudent to implement routine OME screening in these vulnerable children to enable early diagnosis and intervention. Early detection of OME can prevent long-term complications like hearing loss, which may affect speech development and academic performance.
Acknowledgments
We appreciate the kind support from all staff of Department of Otolaryngology-Head & Neck Surgery Faculty of Medicine Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital Bandung.
Disclosure
The authors report no conflicts of interest in this work.
References
1. Batubara JR, Tjahjono HA. Panduan Praktik Klinis Ikatan Dokter Anak Indonesia - Perawakan Pendek pada Anak dan Remaja di Indonesia; 2017.
2. Polidori N, Castorani V, Mohn A, Chiarelli F. Deciphering short stature in children. Ann Pediatr Endocrinol Metab. 2020;25(2):69–79. doi:10.6065/apem.2040064.032
3. U.N.I.C.E.F. UNICEF-WHO-The World Bank: Joint Child Malnutrition Estimates – 2018 edition [Internet]; 2018. Available from: https://data.unicef.org/resources/levels-and-trends-in-child-malnutrition-2018/.
4. Garg P. Short stature in Indian children: experience from a community level hospital. Sri Lanka J Child Health. 2009;34(3):84–88. doi:10.4038/sljch.v34i3.399
5. Sultan M, Afzal M, Qureshi SM, et al. Etiology of short stature in children. J Coll Physicians Surg Pak. 2008;18(8):493–497.
6. Lembaga Penerbit Badan Litbang Kesehatan. Laporan Provinsi Jawa Barat RISKESDAS 2018; 2018. Available from: https://ejournal2.litbang.kemkes.go.id/index.php/lpb/article/view/3662.
7. Abella V, Scotece M, Conde J, et al. Leptin in the interplay of inflammation, metabolism and immune system disorders. Nat Rev Rheumatol. 2017;13(2):100–109. doi:10.1038/nrrheum.2016.209
8. Kiernan K, MacIver NJ. The role of the adipokine leptin in immune cell function in health and disease. Front Immunol. 2021;11. doi:10.3389/fimmu.2020.622468
9. Chu YW, Schmitz S, Choudhury B, et al. Exogenous insulin-like growth factor 1 enhances thymopoiesis predominantly through thymic epithelial cell expansion. Blood. 2008;112(7):2836–2846. doi:10.1182/blood-2008-04-149435
10. Savino W, Dardenne M, Velloso LA, Dayse Silva-Barbosa S. The thymus is a common target in malnutrition and infection. Br J Nutr. 2007;98(Suppl 1):S11–16. doi:10.1017/S0007114507832880
11. Gil Á, Plaza-Diaz J, Mesa MD. Vitamin D: classic and novel actions. Ann Nutr Metab. 2018;72(2):87–95. doi:10.1159/000486536
12. Cayir A, Turan MI, Ozkan O, Cayir Y, Kaya A, Davutoglu S. Serum vitamin D levels in children with recurrent otitis media. Eur Arch Otorhinolaryngol. 2014;271:689–693. doi:10.1007/s00405-013-2455-7
13. Salem MAM, Abdullah MM, Mohamed ZA, Gad MOA, Gadalla WG. Vitamin D levels in children diagnosed with acute otitis media. Egypt J Otolaryngol. 2019;35(2):162–167. doi:10.4103/ejo.ejo_59_18
14. Mokhtar RR, Holick MF, Sempértegui F, et al. Vitamin D status is associated with underweight and stunting in children aged 6–36 months residing in the Ecuadorian Andes. Public Health Nutr. 2018;21(11):1974–1985. doi:10.1017/S1368980017002816
15. Walli NZ, Munubhi EK, Aboud S, Manji KP. Vitamin D levels in malnourished children under 5 years in a tertiary care center at Muhimbili National Hospital, Dar es Salaam, Tanzania–a cross-sectional study. J Trop Pediatr. 2017;63(3):203–209. doi:10.1093/tropej/fmw081
16. Gombart AF. The vitamin D–antimicrobial peptide pathway and its role in protection against infection. Future Microbiol. 2009;4:1151. doi:10.2217/fmb.09.87
17. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011;96(7):1911–1930. doi:10.1210/jc.2011-0385
18. Brustad N, Chawes B. Vitamin D primary prevention of respiratory infections and Asthma in early childhood: evidence and mechanisms. J Allergy Clin Immunol Pract. 2024;12(7):1707–1714. doi:10.1016/j.jaip.2024.02.005
19. Gaudet M, Plesa M, Mogas A, Jalaleddine N, Hamid Q, Al Heialy S. Recent advances in vitamin D implications in chronic respiratory diseases. Respir Res. 2022;23(1):252. doi:10.1186/s12931-022-02147-x
20. Kuraoka S, Oda M, Mitsubuchi H, Nakamura K, Katoh T. Impaired height growth associated with vitamin D deficiency in young children from the Japan Environment and Children’s Study. Nutrients. 2022;14(16):3325. doi:10.3390/nu14163325
21. Xiao P, Cheng H, Wang L, et al. Relationships for vitamin D with childhood height growth velocity and low bone mineral density risk. Front Nutr. 2023:10. doi:10.3389/fnut.2023.1081896
22. Xu B, Feng Y, Gan L, et al. Vitamin D status in children with short stature: accurate determination of serum vitamin D Components using high-performance liquid chromatography–Tandem mass spectrometry. Front Endocrinol. 2021;12:707283. doi:10.3389/fendo.2021.707283
23. Inzaghi E, Pampanini V, Deodati A, Cianfarani S. The effects of nutrition on linear growth. Nutrients. 2022;14(9):1752. doi:10.3390/nu14091752
24. Karimian E, Chagin AS, Sävendahl L. Genetic regulation of the growth plate. Front Endocrinol. 2012;2:113. doi:10.3389/fendo.2011.00113
25. Esposito S, Leonardi A, Lanciotti L, Cofini M, Muzi G, Penta L. Vitamin D and growth hormone in children: a review of the current scientific knowledge. J Transl Med. 2019;17:87. doi:10.1186/s12967-019-1840-4
26. Zhang Y, Xu M, Zhang J, Zeng L, Wang Y, Zheng QY. Risk factors for chronic and recurrent otitis media–a meta-analysis. PLoS One. 2014;9(1):e86397. doi:10.1371/journal.pone.0086397
27. Chen YH, Spencer S, Laurence A, Thaventhiran JE, Uhlig HH. Inborn errors of IL-6 family cytokine responses. Curr Opin Immunol. 2021;72:135–145. doi:10.1016/j.coi.2021.04.007
28. Schilder AGM, Chonmaitree T, Cripps AW, et al. Otitis media. Nat Rev Dis Primer. 2016;2(1):16063. doi:10.1038/nrdp.2016.63
29. Iyer SS, Cheng G. Role of Interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol. 2012;32(1):23–63. doi:10.1615/CritRevImmunol.v32.i1.30
30. Park M, Lee JS, Lee JH, Oh SH, Park MK. Prevalence and risk factors of chronic otitis media: the Korean National Health and Nutrition Examination Survey 2010–2012. PLoS One. 2015;10(5):e0125905. doi:10.1371/journal.pone.0125905
31. Aranow C. Vitamin D and the immune system. J Investig Med off Publ Am Fed Clin Res. 2011;59(6):881–886. doi:10.2310/JIM.0b013e31821b8755
32. Balan KV, Babu US, Godar DE, Calvo MS. Vitamin D and respiratory infections in infants and toddlers: a nutri-shine perspective. Handb Vitam Hum Health. 2013;4:276–297. doi:10.3920/978-90-8686-765-3_16
33. Yu EA, Huey SL, Peña-Rosas JP, Mehta S. The effects of oral vitamin D supplementation on linear growth and non-communicable diseases among infants and children younger than five years of age. Cochrane Database Syst Rev. 2017. doi:10.1002/14651858.CD012875
34. Salamah M, Alghamdi A, Mania K, et al. Association between vitamin D and ear disease: a meta-analysis and systematic review. Egypt J Otolaryngol. 2022;38(1):27. doi:10.1186/s43163-022-00199-w
35. Li HB, Tai XH, Sang YH, et al. Association between vitamin D and development of otitis media: a PRISMA-compliant meta-analysis and systematic review. Medicine. 2016;95(40):e4739. doi:10.1097/MD.0000000000004739
36. Serban R, Filip C, Radulescu LM, et al. IL-1α, IL-6 and IL-8 serum values in patients with chronic suppurative otitis media. Exp Ther Med. 2021;22(5):1226. doi:10.3892/etm.2021.10660
© 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 4.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
Recommended articles
Based on the Dual Pathway of Interaction-Mediated NF-κB in Cell Apoptosis and Immune Inflammation to Study the Effect of Danzhi Xiaoyao Powder on the Learning and Cognitive Ability of AD Model Rats
Wang HP, Li MC, Yang J, Zhou J, Meng ZP, Hu YY, Lyu YJ, Chen YQ, Han YM, Pei WL
Degenerative Neurological and Neuromuscular Disease 2025, 15:41-64
Published Date: 14 April 2025